Yang ZL - Search Results

1

Comparing prognostic values of the 7th and 8th editions of the American Joint Committee on Cancer TNM staging system for gastric cancer.

Zhu MH, Zhang KC, Yang ZL, Qiao Z, Chen L. Zhu MH, et al. Among authors: yang zl. Int J Biol Markers. 2020 Mar;35(1):26-32. doi: 10.1177/1724600819891585. Epub 2019 Dec 16. Int J Biol Markers. 2020. PMID: 31841062 Free article.

2

Prognostic Value of the Number of Lymph Nodes Examined in Patients with Node-Negative Gastric Cancer.

Yang ZL, Zhu MH, Shi Q, Lu FM, Wang CX. Yang ZL, et al. J Gastrointest Surg. 2019 Mar;23(3):460-467. doi: 10.1007/s11605-018-3947-y. Epub 2018 Sep 17. J Gastrointest Surg. 2019. PMID: 30225793

3

A Novel Oxidative Phosphorylation-Associated Gene Signature for Prognosis Prediction in Patients with Hepatocellular Carcinoma.

Chen W, Yang Z, Chen Y. Chen W, et al. Dis Markers. 2022 Sep 5;2022:3594901. doi: 10.1155/2022/3594901. eCollection 2022. Dis Markers. 2022. PMID: 36105252 Free PMC article.

4

Development and Validation of a Vascular Endothelial Growth Factor A-associated Prognostic Model for Unresectable Hepatocellular Carcinoma.

He K, Liu X, Yang Z. He K, et al. J Hepatocell Carcinoma. 2023 Feb 5;10:139-156. doi: 10.2147/JHC.S399299. eCollection 2023. J Hepatocell Carcinoma. 2023. PMID: 36777498 Free PMC article.

5

AQP5 Is a Novel Prognostic Biomarker in Pancreatic Adenocarcinoma.

Chen G, Song H, Yang Z, Du T, Zheng Y, Lu Z, Zhang K, Wei D. Chen G, et al. Front Oncol. 2022 May 10;12:890193. doi: 10.3389/fonc.2022.890193. eCollection 2022. Front Oncol. 2022. PMID: 35619903 Free PMC article.

6

GATA1 Promotes Gemcitabine Resistance in Pancreatic Cancer through Antiapoptotic Pathway.

Chang Z, Zhang Y, Liu J, Guan C, Gu X, Yang Z, Ye Q, Ding L, Liu R. Chang Z, et al. J Oncol. 2019 Apr 10;2019:9474273. doi: 10.1155/2019/9474273. eCollection 2019. J Oncol. 2019. PMID: 31093285 Free PMC article.

7

Tubulin-binding peptide RR-171 derived from human umbilical cord serum displays antitumor activity against hepatocellular carcinoma via inducing apoptosis and activating the NF-kappa B pathway.

Zhu D, Fang C, Yang Z, Ren Y, Yang F, Zheng S, Jiang M, Miao X, Liu D, Chen B, Yao X, Chen Y. Zhu D, et al. Cell Prolif. 2022 May;55(5):e13241. doi: 10.1111/cpr.13241. Epub 2022 May 3. Cell Prolif. 2022. PMID: 35504605 Free PMC article.

8

Inhibition of neddylation modification by MLN4924 sensitizes hepatocellular carcinoma cells to sorafenib.

Yang Z, Zhang J, Lin X, Wu D, Li G, Zhong C, Fang L, Jiang P, Yin L, Zhang L, Bie P, Xie CM. Yang Z, et al. Oncol Rep. 2019 Jun;41(6):3257-3269. doi: 10.3892/or.2019.7098. Epub 2019 Apr 4. Oncol Rep. 2019. PMID: 31002342 Free PMC article.

9

Identification of Potential Predictors of Prognosis and Sorafenib-Associated Survival Benefits in Patients with Hepatocellular Carcinoma after Transcatheter Arterial Chemoembolization.

He K, Yang Z, Liu X, Yang Y, Song W, Wang S, Chen Y. He K, et al. Curr Oncol. 2022 Dec 29;30(1):476-491. doi: 10.3390/curroncol30010038. Curr Oncol. 2022. PMID: 36661687 Free PMC article.

10

Risk factors analysis of surgical complications of hepatic hemangioma: a modified Clavien-Dindo classification-based study.

Yang K, Ma Y, Yang Z, Yang Y, Song W, Chen W, Lv W, Zhang R, Chen Y, Qiao H. Yang K, et al. BMC Surg. 2023 May 6;23(1):111. doi: 10.1186/s12893-023-02009-3. BMC Surg. 2023. PMID: 37149572 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

654 results

Search Page

Filters